A Phase 2 Study of RTA 402 in CKD Patients With Type 2 Diabetes Mellitus

Trial Profile

A Phase 2 Study of RTA 402 in CKD Patients With Type 2 Diabetes Mellitus

Discontinued
Phase of Trial: Phase II

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Bardoxolone methyl (Primary)
  • Indications Renal failure; Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Kyowa Hakko Kirin
  • Most Recent Events

    • 11 Nov 2013 Status changed from suspended to discontinued, as reported in a Kyowa Hakko Kirin media release.
    • 19 Oct 2012 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 19 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top